R
Ricardo Gandara
Researcher at University of Manchester
Publications - 8
Citations - 1194
Ricardo Gandara is an academic researcher from University of Manchester. The author has contributed to research in topics: Cancer cell & Stromal cell. The author has an hindex of 8, co-authored 8 publications receiving 1060 citations.
Papers
More filters
Journal ArticleDOI
Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts.
Diana Whitaker-Menezes,Ubaldo E. Martinez-Outschoorn,Zhao Lin,Adam Ertel,Neal Flomenberg,Agnieszka K. Witkiewicz,Ruth Birbe,Anthony Howell,Stephanos Pavlides,Ricardo Gandara,Richard G. Pestell,Federica Sotgia,Federica Sotgia,Nancy J. Philp,Michael P. Lisanti,Michael P. Lisanti +15 more
TL;DR: The results directly show that breast cancer cells specifically induce the expression of MCT4 in cancer-associated fibroblasts, and provide the first evidence for the existence of a stromal-epithelial lactate shuttle in human tumors, analogous to the lactate shuttles that are essential for the normal physiological function of muscle tissue and brain.
Journal ArticleDOI
Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis.
Stephanos Pavlides,Iset Medina Vera,Ricardo Gandara,Sharon Sneddon,Richard G. Pestell,Isabelle Mercier,Ubaldo E. Martinez-Outschoorn,Diana Whitaker-Menezes,Anthony Howell,Federica Sotgia,Michael P. Lisanti +10 more
TL;DR: A new two-compartment model for understanding tumor metabolism is proposed, which adds a novel stromal twist to two very well-established cancer paradigms: aerobic glycolysis and autophagy.
Journal ArticleDOI
Using the “reverse Warburg effect” to identify high-risk breast cancer patients: Stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers
Agnieszka K. Witkiewicz,Diana Whitaker-Menezes,Abhijit Dasgupta,Nancy J. Philp,Zhao Lin,Ricardo Gandara,Sharon Sneddon,Ubaldo E. Martinez-Outschoorn,Federica Sotgia,Federica Sotgia,Michael P. Lisanti,Michael P. Lisanti +11 more
TL;DR: The “Reverse Warburg Effect” or “parasitic” energy-transfer is a key determinant of poor overall patient survival and MCT4 inhibitors should be developed for the treatment of aggressive breast cancers, and possibly other types of human cancers.
Journal ArticleDOI
Graphene oxide selectively targets cancer stem cells, across multiple tumor types: implications for non-toxic cancer treatment, via "differentiation-based nano-therapy".
Marco Fiorillo,Marco Fiorillo,Andrea Francesco Verre,Maria Iliut,Maria Peiris-Pagès,Béla Ózsvári,Ricardo Gandara,Anna Rita Cappello,Federica Sotgia,Aravind Vijayaraghavan,Michael P. Lisanti +10 more
TL;DR: Graphene oxide is shown to be an effective non-toxic therapeutic strategy for the eradication of cancer stem cells, via differentiation-based nano-therapy and Mechanistically, it is presented evidence that GO exerts its striking effects on CSCs by inhibiting several key signal transduction pathways and thereby inducing CSC differentiation.
Journal ArticleDOI
Mitochondrial dysfunction in breast cancer cells prevents tumor growth: understanding chemoprevention with metformin.
Rosa Sánchez-Alvarez,Ubaldo E. Martinez-Outschoorn,Rebecca Lamb,James Hulit,Anthony Howell,Ricardo Gandara,Marina Sartini,Emanuel Rubin,Michael P. Lisanti,Federica Sotgia +9 more
TL;DR: The beneficial anticancer effects of mitochondrial inhibitors (such as metformin) may be attributed to the induction of mitochondrial dysfunction in the epithelial cancer cell compartment, which identifies cancer cell mitochondria as a clear target for drug discovery and for novel therapeutic interventions.